Company / Income Tax per Share
Sarepta Therapeutics Income Tax per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
$0.12
FY2025
5-year range
-$0.00 / $0.27
FY2021-FY2025
Trend
-57.6%
vs FY2024
Sector context
#43 of 201
Health Care
What the data says
Sarepta Therapeutics's income tax per share of $0.12 is higher than 79% of companies in the Health Care sector (FY2025). Income Tax per Share has fluctuated over the past 9 years, ranging from $-0.01 in FY2018 to $0.27 in FY2024.
Based on SEC 10-K filings.
0.12 in FY2025 with a 3-year CAGR of +111.5%. Top quartile in the Health Care sector.
Improved from $0.18 to $0.12 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- +111.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-91.4% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 57.6% year-over-year.
- Ranks #43 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2024.
- Lowest income tax per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.12 | -57.6% |
| FY2024 | $0.27 | +50.9% |
| FY2023 | $0.18 | +1379.8% |
| FY2022 | $0.01 | +676.4% |
| FY2021 | -$0.00 | +77.0% |
| FY2020 | -$0.01 | -131.8% |
| FY2019 | $0.03 | +371.4% |
| FY2018 | -$0.01 | -128.4% |
| FY2017 | $0.04 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026